JAKARTA, Nov 30 (Reuters): Emerging Asian equities and currencies trimmed gains on Tuesday on concerns that the Omicron coronavirus variant could prove more resistant to existing vaccines, while South Korean shares dropped over 2% on weak domestic data.
Risk sentiment across Asia soured after the head of drugmaker Moderna told the Financial Times that current Covid-19 vaccines were unlikely to be as effective against Omicron as they have been against the Delta variant.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!